# Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

> **NCT00080808** · PHASE2 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 111 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Alprostadil (E1)
- **DRUG:** Papaverine
- **DRUG:** Phentolamine mesylate
- **DRUG:** Sildenafil citrate
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00080808
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2006-07
- **Final completion:** 2009-07
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2012-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00080808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00080808, "Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00080808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*